Chemical news · Three minutes a day
Saturday, October 3, 2026
Lead Story
Milei Discusses Argentina LNG Project with Eni CEOArgentine President Milei discussed the 12-million-tonne-per-year Argentina LNG project with Eni CEO, targeting production start by 2030 in the Vaca Muerta basin alongside partners YPF and XRG.
Portuguese oil major Galp Energia is exploring options to sell or partner on its 2.7-gigawatt renewable energy portfolio, mirroring recent restructuring activities by European peers like TotalEnergies and EDP Renewables.
A Kenyan consumer group challenged Dangote's $16 billion Lamu refinery over compliance issues, marking the second legal hurdle for the facility. President Ruto insists the plant will proceed to reduce fuel imports, though the dispute risks delaying construction.
German state-owned energy firm SEFE has hired Lazard to explore reprivatisation options, with a sales process expected in 2027 to comply with EU rules reducing government ownership stakes.
The Consumers Federation of Kenya challenged Dangote's $16 billion oil refinery project over transparency and land rights concerns. A hearing is scheduled for October 14 regarding the 700,000-barrel-per-day facility slated for completion in 2030.
The US Coast Guard intercepted the cargo vessel 'Grace' in the Caribbean, confirming it carried fuel bound for Cuba amidst ongoing US oil embargoes and sanctions.
Novartis has entered into a $7.8 billion licensing and option agreement with Chinese biotech firm Abogen to advance RNA-based therapies.
Poland imposes windfall taxes on the energy sector and cuts fuel VAT to curb rising prices after President Nawrocki reversed his stance. The measures aim to reduce inflation and cap pump costs, raising 4 billion zloty from oil companies like Orlen.
Gunvor Group has renamed itself Centalion Group Ltd. and plans to redomicile its headquarters to Singapore following a management buyout and scrutiny over its Russian ownership ties.
Corteva spun off its seed business into Vylor to concentrate on crop protection, aiming for $1 billion in biologicals sales by 2030. This move aligns with broader industry reshaping by competitors like BASF and FMC amid pricing pressures.
ChemBrief